4
Changes in Ownership
BIODESIX INC Filed Acc 0001140361-22-018736
Chief Commercial Officer sold 1,583 shares at $1.83 ($2,897)
- Chief Commercial Officer acquired 5,461 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
O'Kane Kieran · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-09 | Exercise or conversion : show line 1 in the form | +5,461 | 9,222 | D | ||
| 2022-05-10 | Sale : show line 2 in the form | −1,583 | $1.83 | $2,897 | 7,639 | D |
| Open-market sales · 1,583 sh · avg $1.83 · $2,897 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2022-05-09 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −1,489 | 1,489 | 22,342 | D |
| 2022-05-09 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −3,972 | 3,972 | 19,859 | D |
Loading xslF345X03/form4.xml…